Paper Details

  1. Home
  2. Paper Details

Preference studies of triazolam with standard hypnotics in out-patients with insomnia.

Author: FabreL F, HarrisR T, McLendonD M

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Triazolam, a new triazolobenzodiazepine, was preferred by more patients and was superior to placebo, flurazepam, and chloral hydrate in treating insomnia. Triazolam also produced fewer side effects than the other treatments.
Paper Details　
Original Abstract of the Article :
One hundred and four patients suffering from insomnia took part in four different two-night double-blind crossover trials of triazolam. In three separate studies, triazolam 0-5 mg was compared to placebo, flurazepam 30 mg and chloral hydrate 500 mg. Triazolam 0-5 mg was found to be preferred and to ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/030006057600400407

データ提供：米国国立医学図書館（NLM）

Triazolam: A New Star in the Sleepscape

This study, published in 1978, investigates the effectiveness of triazolam, a newly developed hypnotic medication, in treating insomnia. The researchers, like astronomers mapping the stars, compared the effects of triazolam to other established hypnotics, including flurazepam and chloral hydrate, in a series of double-blind, crossover trials involving 104 outpatients with insomnia.

Triazolam: A Superior Choice

The study revealed that triazolam, like a bright star illuminating the night sky, was preferred by patients and was superior to placebo and other hypnotics in promoting sleep, reducing sleep onset latency, and improving overall sleep quality. These findings suggest that triazolam might be a promising new option for those seeking relief from insomnia.

Navigating the Desert of Insomnia

It is important to remember that every camel's sleep needs are unique. The right treatment for you will depend on your individual needs and health history. Always consult with a healthcare professional to determine the most suitable hypnotic for your sleep difficulties.

Dr. Camel's Conclusion

This study, like a caravan journey across a star-filled desert, offers valuable insights into the effectiveness of triazolam as a hypnotic medication. The research highlights the potential of triazolam to provide relief for those struggling with insomnia, offering a beacon of hope for a good night's sleep.
Date :
  1. Date Completed 1977-07-23
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

16801

DOI: Digital Object Identifier

10.1177/030006057600400407

Related Literature

Article Analysis
・Effects of triazolam
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.